[54] Antioxidant activity of Nitecapone (cas 116313-94-1) and its analog OR-1246: Effect of structural modification on antioxidant action
-
Add time:08/10/2019 Source:sciencedirect.com
Publisher SummaryThis chapter discusses the antioxidant activity of Nitecapone (cas 116313-94-1) and its analog OR-1246. The effect of structural modification on antioxidant action is also described. Nitecapone is an effective peripherally acting inhibitor of catechol O-methyl-transferase. Nitecapone scavenges superoxide, hydroxyl, and peroxyl radicals generated either in solution or in membranes, protects membranes from lipid peroxidation, recycles vitamin E through a reaction with ascorbate, and inhibits xanthine oxidase activity. The compound also form a reversible adduct with glutathione, and protect this thiol from oxidative depletion. Nitecapone exerts gastroprotective effects in various models of gastric and duodenal ulcers, and it is being evaluated in a clinical study as an antiulcer drug. Although the stimulation of duodenal bicarbonate secretion mediated by nitecapone through the inhibition of catechol O-methyltransferase activity could explain the gastroprotective effect, the antioxidant properties of the molecule could also contribute to this protection. The chapter describes the methods used to assess the effects of the distinctive structural and physicochemical properties of nitecapone and OR-1246 on their respective antioxidant activities.
We also recommend Trading Suppliers and Manufacturers of Nitecapone (cas 116313-94-1). Pls Click Website Link as below: cas 116313-94-1 suppliers
Prev:Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: Effect of Nitecapone (cas 116313-94-1)
Next:Pain Behavior and Response Properties of Spinal Dorsal Horn Neurons Following Experimental Diabetic Neuropathy in the Rat: Modulation by Nitecapone (cas 116313-94-1), a COMT Inhibitor with Antioxidant Properties) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Pain Behavior and Response Properties of Spinal Dorsal Horn Neurons Following Experimental Diabetic Neuropathy in the Rat: Modulation by Nitecapone (cas 116313-94-1), a COMT Inhibitor with Antioxidant Properties08/11/2019
- Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: Effect of Nitecapone (cas 116313-94-1)08/09/2019
- Determination of a catechol-O-methyltransferase inhibitor, Nitecapone (cas 116313-94-1), in human plasma and urine by liquid chromatography08/08/2019
- Protection against alcohol-induced gastric mucosal injury by Nitecapone (cas 116313-94-1)08/07/2019
- Nitecapone (cas 116313-94-1) as an additive to crystalloid cardioplegia in patients who had coronary artery bypass grafting08/06/2019
- Nitecapone (cas 116313-94-1) effect on the synthesis and secretion of gastric sulfomucin08/05/2019
- Role of ascorbate in protection by Nitecapone (cas 116313-94-1) against cardiac ischemia-reperfusion injury08/04/2019
- Antioxidant properties of Nitecapone (cas 116313-94-1) (OR-462)08/03/2019
- Nitecapone (cas 116313-94-1) reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats08/02/2019


